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Background: Congenital mitral regurgitation is a rare condition and can be challenging to manage
when presenting in the neonatal period
Objectives/Goal: Two week old male presented with poor weight gain, murmur and cardiomegaly
on chest X-ray. Echocardiogram showed moderate to severe mitral regurgitation (MR) and
suprasystemic pulmonary hypertension (PHN) (fig 1 a, b). The mitral valve (MV) leaflets were
thickened and tethered with failure of central coaptation. PHN was classified as WHO I and II (due
to persistent PHN of newborn and MR respectively). Inhaled nitric oxide, Enalapril and Furosemide
were initiated. Cardiac catheterization revealed PVRi of 8.9 WU x m2 and CT was non-specific for
lung parenchymal disease. Sildenafil and Flolan were added to reverse PHN prior to proceeding
with MV repair. At 4 weeks of age he underwent mitral valvuloplasty which was complicated by
severe MR and left heart failure (fig 1 c-d). Successful MV replacement with 17 mm St Jude
mechanical valve was performed at 11 weeks (fig 1 e). PHN medications were weaned and patient
is now ready for discharge.
Methods/Design: Patient presented with severe left heart failure and PHN secondary to severe
congenital MR. MV intervention was indicated due to failed medical management. While MV
replacement, can be a challenge, it was ultimately necessary given the severe post repair residual
regurgitation.

Results:
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Figure 1. Echocardiographic imaging and graphic trends
a.Apical image of severe congenital mitral regurgitation on presentation. b. CW doppler of tricuspid regurgitation jet estimating
suprasystemic right ventricular pressures on presentation. c. Post- operative TEE after MV repair showing persistent severe MR.
d. Graphic trends of left atrial volume prior to MV replacement. e. Graphic trends of left ventricular end diastolic volume; the last
4 data points were obtained after MV replacement.

Conclusions: This case highlights the complexity of decision making for congenital MR, and the
role of MV replacement in the case of failed repair.

